Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 0 | 0 | 251 | 395 | 179 |
| Gross Profit | 0 | N/A | 251 | 395 | 179 |
| Operating Expenses | 4,118 | 4,089 | 1,791 | 1,710 | 1,912 |
| Operating Income | -4,118 | -4,089 | -1,540 | -1,315 | -1,733 |
| Interest Expense | 47 | 62 | 263 | 1 | 1 |
| Other Income | 0 | 0 | 0 | 0 | 240 |
| Pre-tax Income | -4,165 | -4,151 | -1,803 | -1,316 | -1,494 |
| Net Income Continuous | -4,165 | -4,151 | -1,803 | -1,316 | -1,494 |
| Net Income Discontinuous | -96 | -51 | -129 | -103 | -102 |
| Net Income | $-4,261 | $-4,202 | $-1,932 | $-1,419 | $-1,596 |
| EPS Basic Total Ops | 0.24 | -0.40 | -1.00 | -0.80 | -1.00 |
| EPS Basic Continuous Ops | 0.10 | -0.40 | -1.00 | -0.60 | -0.80 |
| EPS Basic Discontinuous Ops | 0.06 | -0.01 | -0.06 | -0.05 | -0.05 |
| EPS Diluted Total Ops | 0.24 | -0.40 | -1.00 | -0.80 | -1.00 |
| EPS Diluted Continuous Ops | 0.10 | -0.40 | -1.00 | -0.60 | -0.80 |
| EPS Diluted Discontinuous Ops | 0.06 | -0.01 | -0.06 | -0.05 | -0.05 |
| EBITDA(a) | $-4,037 | $-4,007 | $-1,469 | $-1,267 | $-1,684 |